4//SEC Filing
Hall Brett Matthew 4
Accession 0001790340-25-000111
CIK 0001790340other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 4:30 PM ET
Size
5.6 KB
Accession
0001790340-25-000111
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Class A Common Stock
2025-09-15$1.43/sh+14,880$21,249→ 374,198 total
Footnotes (3)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the issuer's Class A Common Stock pursuant to the Immuneering Corporation 2021 Employee Stock Purchase Plan (the "ESPP"), for the ESPP purchase period of March 16, 2025 through September 15, 2025. This transaction is also exempt pursuant to Rule 16b-3(c) promulgated pursuant to the Securities Exchange Act of 1934.
- [F2]The relevant Offering Period (as defined in the ESPP) ended, and the shares were acquired, on the Purchase Date (as defined in the ESPP) of September 15, 2025.
- [F3]In accordance with the ESPP, the shares were purchased at a price not less than eighty-five percent (85%) of the Fair Market Value (as defined in the ESPP) of a share of Class A Common Stock on the Enrollment Date (as defined in the ESPP) of the relevant Offering Period.
Documents
Issuer
Immuneering Corp
CIK 0001790340
Entity typeother
Related Parties
1- filerCIK 0001870437
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 4:30 PM ET
- Size
- 5.6 KB